Stocks
HOFSETH BIOCARE ASA: MANDATORY NOTIFICATION OF TRADE
Reference is made to the stock exchange announcements from Hofseth BioCare ASA ("HBC" or the "Company") published on 26 June 2026 and 29 June 2026 regarding a private placement (the "Private Placement") of new ordinary shares ("Offer Shares") at a fixed price per share of NOK 1.30 (the "Offer Price"), which raised gross proceeds of approximately NOK 144.5 million. In the Private Placement, the following primary insiders or close associates of primary insiders were allocated Offer Shares in the P
About this update from Hofseth Biocare Asa
Reference is made to the stock exchange announcements from Hofseth BioCare ASA ("HBC" or the "Company") published on 26 June 2026 and 29 June 2026 regarding a private placement (the "Private Placement") of new ordinary shares ("Offer Shares") at a fixed price per share of NOK 1.30 (the "Offer Price"), which raised gross proceeds of approximately NOK 144.5 million. In the Private Placement, the following primary insiders or close associates of primary insiders were allocated Offer Shares in the Private Placement: For further information, please see the attached notification forms. The issuance of Offer Shares to Hofseth International AS and Bomi Framroze Holding AS remains subject to approval by an extraordinary general meeting, expected to be held on or about 30 July 2026, however the Company has secured sufficient voting undertakings in order to ensure that this resolution will be passed at the extraordinary general meeting. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19. For further information, please contact: Jon Olav Ødegård, CEO at HBCPhone: +47 936 32 966E-mail: [email protected] Attachments
View stock analysis, news, and events for Hofseth Biocare Asa